Company intelligence / Profile preview
Ratiopharm
Ulm, Baden-Württemberg, Germanyratiopharm.de ↗
- Ownership
- Private
- Employees
- ~4000
- Development stage
- Commercial
01
Overview
Ratiopharm has one of the widest product ranges in the generics business with about 750 medicines available exclusively from pharmacies. The company sells approximately 472 million pack units annually and meets needs across virtually all areas of medicine. Nearly 400 products are at the approval stage[5]. As a generics company, it does not conduct traditional clinical trials for new chemical entities but demonstrates bioequivalence to originator drugs.
- Therapeutic areas
- Other
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Founding member of Pro Generika association alongside Stada and Hexal for industry lobbying in Germany
Beyond the preview
Go deeper on Ratiopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ratiopharm.